Unlocking the electrochemical signature of Naringenin: Implications for screening in pharmaceutical formulations.

[Display omitted] • First comparative report on the electrochemical behavior of NAR using unmodified electrodes. • Selective and sustainable electroanalytical method for detecting NAR. • Linear range of 1.36 to 19.1 mg L-1 (LOD 0.11 mg L-1) for GCE. • Electronic structure of NAR probed using B3LYP/Def2-TZVPPD calculations alongside Fukui and dual descriptor analyses. • Cost-effective strategy for electroanalysis of pharmaceutical formulations. Naringenin (NAR) is a versatile herbal flavonoid known for its broad pharmacological benefits, including antioxidant, anti-inflammatory, and anticancer properties. These properties underscore its potential and necessity for industrial applications within the pharmaceutical sector, making its detection and quantification crucial for ensuring the quality and efficacy of pharmaceutical products. Addressing the imperative for a sensitive and sustainable screening approach, this research leverages electrochemical analysis techniques including electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). Complementary to experimental investigations, the electronic structure of NAR was probed using B3LYP/Def2-TZVPPD calculations alongside Fukui and dual descriptor analyses. Our findings delineate the dissociation kinetics of the hydroxyl groups within NAR, with particular emphasis on the phenolic group's proton as the primary dissociation site, elucidating pivotal insights into the oxidation mechanism of NAR. Noteworthy is the irreversibility of the electrochemical oxidation process observed on both non-modified glassy carbon electrode (GCE) and gold electrode (GE), indicating a one-electron-one-proton mechanism. Utilizing the external calibration method and GCE, a linear range from 1.36 to 19.1 mg L-1 in Britton-Robinson (BR) supporting electrolyte was established, exhibiting a limit of detection (LOD) of 0.11 mg L-1 (R2 = 0.9945). For GE, the standard addition calibration approach revealed one linear range, from 0.27 to 0.48 mg L-1 (LOD of 0.04 mg L-1, R2 = 0.9960). Importantly, the proposed methodologies demonstrate satisfactory selectivity against potential interferences, with intra- and inter-day precision exhibiting low relative standard deviation (RSD) values. This study introduces a simple, sensitive, stable, selective, and sustainable electroanalytical method for the detection of NAR in pharmaceutical formulations, harnessing the advantages of unmodified electrodes and rigorous experimental validation. [ABSTRACT FROM AUTHOR]